Conferences

 

 

1st INTERNATIONAL CLINICAL DEVELOPMENT CONGRESS ON CELL

THERAPIES AND TISSUE ENGINEERING

Date: 23rd-24th October 2008

Location: Central London, UK (Venue TBC)

OVERVIEW......................................................................................................................

Advancements in stem cell research and tissue engineering hold the promise of a new trove of regenerative therapies to treat diseases and conditions by restoring or repairing genetic and cellular defects. Over the past decade alone billions of dollars of investment have poured into the sector, and with over 550 global companies developing or collaborating on regenerative products, the clinical development stakes are high. Understanding the current challenges and the technological advances is critical for successful transition from bench to clinic.

Arrowhead-Spectra's 1st International Clinical Development Congress on Cell Therapies and Tissue Engineering is the forum to decipher the progress of clinical-phase candidates and technologies that have the potential to succeed in the highly competitive global marketplace. Based on presentations of case studies, trials, and proprietary data, the conference will be an unmissable event that focuses pioneering clinical development work.

Presentation topics to include:

  • Therapeutic Potential of PLX Placental Mesenchymal Stromal Cells;
  • Current Challenges to Translate Regenerative Medicine Research into Reliable Clinical Products;
  • Intellectual Property and Patent Issues for Regenerative Products;
  • Integrated Solutions for Cell Therapy Product Development and Commercialization;
  • Development of Injectable Scaffolds for Regenerative Medicine Applications;
  • Stem Cell Technology: From Resource to Platforms;
  • Advancing a Pipeline of Cellular Medicines;
  • Regeneration of Articular Cartilage in Osteoarthritis Patients with Mixed Cell Therapy;
  • Big Pharma Investment in Cell Therapies;
  • AMR-001 - An Autologous Bone Marrow Derived Cell Therapy for Cardiovascular Disease;
  • Realising the Potential for Cell-Based Therapeutics: Considerations for Reaching the 'Plateau of Productivity';
  • Human Embryonic Stem Cells and the Path to Regenerative Medicine;
  • Stem Cell Neurogenesis: First-in-Human Trials;
  • Adult Stem Cell Therapy for Acute Cardiovascular Ischaemic Injury;
  • Contract Research and Regenerative Medicine.

Full Brochure and Agenda coming soon...

WHY ATTEND?................................................................................................................................... ...........

  • Determine the progress of current clinical-phase products in cell therapies and tissue engineering;
  • Better understand the challenges and opportunities in stem cells and bioengineering;
  • Learn from pioneering companies on progress of lead products and technologies;
  • Determine the efficacy of clinical stage regenerative products;
  • Establish the market leaders in cell therapy and tissue engineering areas;
  • Network with leaders from bioengineering, pharma-biotechnology and healthcare industries.

Who Should Attend

Individuals from regenerative, biotechnology, pharmaceutical, and capital investment companies will greatly benefit from attending. Researchers and scientists in academia will also find the event useful and informative.

Executive and professional job types may include:

  • Senior executive management: CEO, VP, CSO
  • Research and development executives
  • Academic research scientists
  • Medical scientists
  • Healthcare media organizations
  • Medical and healthcare journalists
  • Venture capitalists

UNABLE TO ATTEND?

If you are unable to attend the conference we are streaming a Live WebCast so that you can access the expert presentations realtime in office or home environments. Webinars of the conference will also be available after the event. The WebCast will be suitable for UK/EU delegates but because of time zone differences, North American and Rest of World delegates may wish to opt for the webinar.

PRICING

10% Early Bird Discounts for registrations before 1st August 2008!..................... (Discounted price shown on RegOnline, but full price shown below):

Full Delegate (attendance at both days): £1,100 | US$2,100

Day-only Delegate (attendance at either day): £750 | US$1,400

Academic and Non-Commercial Delegate: £650 | US$1,200

*Live WebCast Delegate 2-day (UK/EU): £799 | US$1,500

*Live WebCast Delegate 1-day (UK/EU): £499 | US$900 [*North American delegates may wish to receive the Live WebCast but time zone differences may prohibit full access. Please contact us if you wish to access the afternoon session.]

Webinar (Conference archive delivered online after event): £750 | US$1,400

Promotional Literature Distribution: £850 | US$1600 [**Distribution of your company's promotional literature to all full conference delegates]

NB. Prices quoted above in US$ are approximations and currency variations and exchange rates will vary on a daily basis relative to the GB£ price.

VENUE

The Grosvenor at Victoria............................................................................................... 101 Buckingham Palace Road, London SW1W OSJ

For Directions and Hotel Overview click here

HOTEL ACCOMMODATION

Call The Grosvenor reservations direct on +44 (0)20 7868 6248 and quote code 'SPEC231008' to receive special rates on Standard or Executive Suites.

Please use the ebookers.com links below to find flight information and alternative central London hotels

ebookers hotel offers ebookers flights

 

SPONSORSHIP AND MEDIA OPPORTUNITIES

To enquire about sponsorship and/or exhibiting at this conference please contact marketing@arrowheadpublishers.com

CONTACT US

For more infomation about this conference, please contact us at +44(0) 208 671 7726 or email us at conferences@spectraintelligence.com

CANCELLATIONS AND REFUNDS

Conferences Cancellation Policy:

Cancellations received in writing up to 4 weeks before the conference date will be issued a full credit voucher to be applied to another Spectra event within 12 months. Cancellations received in writing later than 4 weeks before the conference date will receive a credit voucher, less a £200 administration fee, to be applied to another Spectra event within 12 months. Delegate substitution is permitted for both registration and credit vouchers. Please contact us at registrations@spectraintelligence.com for further information.

 

View our Privacy Policy here

 

REGENERATIVE

THERAPIES 2008

SPEAKER PANEL INCLUDES:

Professor Dame Julia Polak Department of Chemical Engineering, Tissue Engineering and Regenerative Medicine, Imperial College London, and Co-Founder & Director, NovaThera, UK

................Dr Amir Toren. ...............Director of Business Development Pluristem Therapeutics Inc., Israel

....................Mr George Schlich. ............................................ Schlich & Co., ...................Chartered Patent Agents, UK

.................... ..Dr Robert Deans Senior Vice President of Regenerative Medicine, Athersys Inc., USA

...........................Dr Robin Quirk Co-Founder and Chief Operating Officer, RegenTec Ltd, UK

 

.........................Dr Tim Allsopp. .............Chief Scientific Officer, ....................Stem Cell Sciences Ltd, UK

 

......................Dr Kwan Hee Lee Chief Executive Officer, ...................TissueGene Inc., USA..

.......................Dr Brian Meltzer Senior Director, Venture Program Management, Johnson & Johnson Corporate Development, USA..

....................Dr Sonya Faber Business Development Manager, Fraunhofer Institute for Cell Therapy and Immunology, Germany

 

Plus many more expert speakers...

 

 

 

home | about us | research & analysis | spectra reports | conferences | contact us